» Articles » PMID: 30777109

The Clinical Impacts and Risk Factors for Non-central Line-associated Bloodstream Infection in 5046 Intensive Care Unit Patients: an Observational Study Based on Electronic Medical Records

Overview
Journal Crit Care
Specialty Critical Care
Date 2019 Feb 20
PMID 30777109
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Most of the previous studies focused on central line-associated bloodstream infection (CLABSI), while non-central line-associated bloodstream infection (N-CLABSI) was poorly studied. This study was performed to investigate the clinical impacts and risk factors for N-CLABSI in intensive care unit (ICU) patients.

Methods: An observational study was conducted in an adult general ICU. The electronic medical records from 2013 to 2017 of all patients aged ≥ 18 years admitted to the ICU > 2 days were analyzed retrospectively. Patients with N-CLABSI and without N-CLABSI or with CLABSI were compared for clinical features and outcomes. Predicted death in ICU included death in ICU and discharging from ICU against medical advice because of critical conditions and the desire to pass away at home. Propensity score (PS) matching was used to ensure that both two groups had similar baseline characteristics. Multivariate regression models were used to confirm whether N-CLABSI was an independent risk factor for each of the outcomes and to analyze the risk factors for N-CLABSI in ICU patients.

Results: Of 5046 patients included, 155 developed 168 ICU-acquired N-CLABSI episodes (2.1 episodes per 1000 patient-days) in the ICU, accounted for the majority of nosocomial bloodstream infections (NBSIs; 71.8%). After PS matching, patients with N-CLABSI had prolonged length of stay (LOS) in ICU (median 15 days, p <  0.001) and LOS in hospital (median 13 days, p <  0.001), excess hospitalization costs (median, $27,668 [in US dollar 2017, 1:6.75], p <  0.001), and increased mortality in ICU (8.8%, p = 0.013) and predicted mortality in ICU (22.7%, p <  0.001), compared with those without N-CLABSI. There were no significant differences in all the outcomes between N-CLABSI and CLABSI. N-CLABSI was an independent risk factor for each of the outcomes. Gastrointestinal bleeding (adjusted odds ratio [aOR] 2.30), trauma (aOR 2.52), pancreatitis (aOR 3.45), surgical operation (aOR 1.82), intravascular catheters (aOR 2.93), sepsis (aOR 1.69), pneumonia (aOR 1.53), intraabdominal infection (IAI, aOR 8.37), or healthcare-associated infections other than NBSI, pneumonia, and IAI (aOR 3.89) were risk factors for N-CLABSI in ICU patients.

Conclusions: N-CLABSI was associated with similar poor outcomes with CLABSI, including prolonged LOS in ICU and in hospital and increased hospitalization costs and predicted mortality in ICU. The risk factors for N-CLABSI identified in this study provide further insight in preventing N-CLABSI.

Citing Articles

Prognostic Factors That Affect Mortality Patients with Bloodstream Infection.

Huang C, Gao Y, Lin H, Fan Q, Chen L, Feng Y Infect Drug Resist. 2024; 17:3825-3837.

PMID: 39247754 PMC: 11380481. DOI: 10.2147/IDR.S475073.


Risk of central line-associated bloodstream infections during COVID-19 pandemic in intensive care patients in a tertiary care centre in Saudi Arabia.

Alshamrani M, El-Saed A, Aldayhani O, Alhassan A, Alhamoudi A, Alsultan M Epidemiol Infect. 2024; 152():e95.

PMID: 38825764 PMC: 11736446. DOI: 10.1017/S0950268824000736.


Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness.

Chung K, Su J, Wang Y, Budiarto B, Yeh Y, Cheng J Front Immunol. 2024; 15:1334882.

PMID: 38426112 PMC: 10902670. DOI: 10.3389/fimmu.2024.1334882.


Epidemiology and drug resistance analysis of bloodstream infections in an intensive care unit from a children's medical center in Eastern China for six consecutive years.

Shao H, Zhang X, Li Y, Gao Y, Wang Y, Shao X Int Microbiol. 2024; 27(5):1345-1355.

PMID: 38233723 PMC: 11452477. DOI: 10.1007/s10123-024-00481-2.


Clinical characteristics and prognosis of pneumonia-related bloodstream infections in the intensive care unit: a single-center retrospective study.

Liu Y, Sun T, Cai Y, Zhai T, Huang L, Zhang Q Front Public Health. 2023; 11:1249695.

PMID: 37744495 PMC: 10516289. DOI: 10.3389/fpubh.2023.1249695.


References
1.
Rosenthal V, Guzman S, Migone O, Crnich C . The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. Am J Infect Control. 2003; 31(8):475-80. DOI: 10.1016/j.ajic.2003.03.002. View

2.
OGrady N, Alexander M, Burns L, Dellinger E, Garland J, Heard S . Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis. 2011; 52(9):1087-99. PMC: 3106267. DOI: 10.1093/cid/cir138. View

3.
Almuneef M, Memish Z, Balkhy H, Hijazi O, Cunningham G, Francis C . Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J Hosp Infect. 2005; 62(2):207-13. DOI: 10.1016/j.jhin.2005.06.032. View

4.
Lorente L, Henry C, Martin M, Jimenez A, Mora M . Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care. 2005; 9(6):R631-5. PMC: 1414031. DOI: 10.1186/cc3824. View

5.
Knaus W, Draper E, Wagner D, Zimmerman J . APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818-29. View